Nexus Medical Labs and Rhinostics obtain FDA EUA for SARS-CoV-2 Test
The molecular SARS-CoV-2 test relies on the RHINOstic Automated Nasal Swab from Rhinostics.

The molecular SARS-CoV-2 test relies on the RHINOstic Automated Nasal Swab from Rhinostics.
The company’s fourth quarter worldwide revenue declined by 1% on a reported basis to $8.09bn.
The test identifies gene expression profiles that indicate specific cancers by interrogating mRNA from a whole blood sample.
The device was shown to boost survival and insulin secretion of cells in preclinical models.
The AI-enhanced ECG algorithm uses 12-lead ECGs to diagnose PH at an early stage.
The study was conducted on 4,973 core needle biopsies obtained from three independent arms.
The TSO Comprehensive (EU) test uses a single biopsy specimen to combine less and more prevalent biomarkers.
The AcetaSTAT rapid assay can detect blood markers for injury from an overdose of the drug in about 20 minutes.